| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5563138 | OTSUKA | Benzoheterocyclic compounds |
Oct, 2013
(10 years ago) | |
Raxar is owned by Otsuka.
Raxar contains Grepafloxacin Hydrochloride.
Raxar has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Raxar are:
- US5563138
Raxar was authorised for market use on 06 November, 1997.
Raxar is available in tablet;oral dosage forms.
The generics of Raxar are possible to be released after 08 October, 2013.
Drugs and Companies using GREPAFLOXACIN HYDROCHLORIDE ingredient
Market Authorisation Date: 06 November, 1997
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
RAXAR family patents
